Atlas Trials

Transarterial RAdioembolization Versus ChemoEmbolization for the Treatment of Hepatocellular Carcinoma (HCC)

Clinical trial NCT01381211 · TERMINATED

Trial details

NCT number
NCT01381211
Sponsor
University Hospital, Ghent
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Hepatocellular Carcinoma
Start date
2011-09-01
Primary completion
2018-03-01
Enrollment
72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.